Author

Vicente Diaz, MD, MBA

Dr. Vicente Diaz specializes in ocular inflammatory and infectious diseases at Yale Medicine [link: https://www.yalemedicine.org/doctors/vicente_diaz/] and Yale Health. His research interests include novel immunomodulatory therapies for the treatment of noninfectious inflammatory disease, management of Stevens-Johnsons Syndrome, and innovative therapies in glaucoma. After graduating from ophthalmology residency at Yale University, he completed a fellowship in ocular immunology and infectious disease at The New York Eye & Ear Infirmary, where he was recently on the clinical and research faculty. Dr. Diaz is director of ophthalmology for the Bridgeport Hospital Burn Unit, where he oversees the care of all patients with Stevens-Johnsons Syndrome, a rare and potentially lethal disease. Dr. Diaz founded the La Unidad Latina Medical Guild and was the architect of their annual medical mission to the Dominican Republic, Guatemala, and Honduras, where he performs surgery, teaches residents, and cares for patients in need. Dr. Diaz received his BA from Brown University, his MD from Yale School of Medicine, and his MBA at Yale School of Management.


Medical News Today Editorial Guidelines

Finding health and wellness information is easy. It’s everywhere. But finding trustworthy, relevant, usable information can be hard and even overwhelming. Medical News Today is changing all that. We’re making health information understandable and accessible so you can make the best decisions for yourself and the people you love. Read more about our process